Clinical Trial Update: Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Acute Graft-versus-Host Disease treatment (BMT CTN 0802) completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Graft-versus-Host Disease, Immune System Disorders | Phase 3 | Status: COMPLETED | Results posted: 2016-05-27